BioLife Solutions Files 8-K on Financials

Ticker: BLFS · Form: 8-K · Filed: Aug 8, 2024 · CIK: 834365

Biolife Solutions Inc 8-K Filing Summary
FieldDetail
CompanyBiolife Solutions Inc (BLFS)
Form Type8-K
Filed DateAug 8, 2024
Risk Levellow
Pages1
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, 8-k

Related Tickers: BLFS

TL;DR

BioLife Solutions dropped an 8-K on Aug 8th detailing financial results. Check it out.

AI Summary

BioLife Solutions, Inc. filed an 8-K on August 8, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, providing an update on the company's performance. The company, incorporated in Delaware, is headquartered in Bothell, WA.

Why It Matters

This filing provides investors with crucial, up-to-date information on BioLife Solutions' financial health and operational performance, impacting investment decisions.

Risk Assessment

Risk Level: low — This is a routine financial reporting filing and does not indicate any immediate or significant risks.

Key Players & Entities

  • BioLife Solutions, Inc. (company) — Registrant
  • August 8, 2024 (date) — Date of Report
  • Delaware (jurisdiction) — State of Incorporation
  • Bothell, WA (location) — Principal Executive Offices

FAQ

What specific financial information is being reported in this 8-K?

The 8-K filing indicates it reports on 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.

When was this 8-K filed with the SEC?

The filing date, also the date of the earliest event reported, is August 8, 2024.

What is the principal business address of BioLife Solutions, Inc.?

The principal executive offices are located at 3303 Monte Villa Parkway, Suite 310, Bothell, WA 98021.

What is the Commission File Number for BioLife Solutions, Inc.?

The Commission File Number for BioLife Solutions, Inc. is 001-36362.

What is the IRS Employer Identification Number for BioLife Solutions, Inc.?

The IRS Employer Identification Number for BioLife Solutions, Inc. is 94-3076866.

Filing Stats: 439 words · 2 min read · ~1 pages · Grade level 11 · Accepted 2024-08-08 16:18:11

Key Financial Figures

  • $0.001 — ich registered Common Stock, par value $0.001 per share BLFS The NASDAQ Stock Market

Filing Documents

02 Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition. On August 8, 2024, BioLife Solutions, Inc. (the "Company") issued a press release announcing unaudited financial results and operational highlights for the second quarter ended June 30, 2024. A copy of the press release is furnished as Exhibit 99.1 to this current report on Form 8-K.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release, dated August 8, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BioLife Solutions, Inc. Date: August 8, 2024 By: /s/ Troy Wichterman Name: Troy Wichterman Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.